Cargando…

Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma

Loss of phosphatase and tensin homolog (PTEN) impairs DNA double-strand repair and confers sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPis). However, PARPis also hyperactivate the MAPK and PI3K/AKT/mTOR pathways in PTEN-deficient endometrial carcinoma (EC), which allows the emergence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Huang, Peng, Wang, Liqiong, Chen, Shu, Basappa, Basappa, Zhu, Tao, Lobie, Peter E., Pandey, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209517/ https://www.ncbi.nlm.nih.gov/pubmed/35725817 http://dx.doi.org/10.1038/s41419-022-04982-8

Ejemplares similares

Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma
por: Zhang, Xi, et al.
Publicado: (2022)

Investigation of NPB Analogs That Target Phosphorylation of BAD-Ser99 in Human Mammary Carcinoma Cells
por: Girimanchanaika, Swamy Savvemala, et al.
Publicado: (2021)

Novel Biphenyl Amines Inhibit Oestrogen Receptor (ER)-α in ER-Positive Mammary Carcinoma Cells
por: Basappa, Basappa, et al.
Publicado: (2021)

Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells
por: Kim, Na Young, et al.
Publicado: (2023)

PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
por: Bian, X, et al.
Publicado: (2018)

Electrochemical Synthesis of New Isoxazoles and Triazoles Tethered with Thiouracil Base as Inhibitors of Histone Deacetylases in Human Breast Cancer Cells
por: Vishwanath, Divakar, et al.
Publicado: (2023)

Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase
por: Vishwanath, Divakar, et al.
Publicado: (2022)

De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer Cells
por: Ravish, Akshay, et al.
Publicado: (2023)

Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
por: Cheng, Feifei, et al.
Publicado: (2022)

Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells
por: Basappa, Basappa, et al.
Publicado: (2023)

Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
por: Chen, Ru-Mei, et al.
Publicado: (2019)

Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells
por: Ravish, Akshay, et al.
Publicado: (2023)

Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
por: Poh, Han Ming, et al.
Publicado: (2019)

New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021)

Steroid Hormone Intervenes in the Endometrial Tumorigenesis of Pten Ablation
por: Kim, Hong Im, et al.
Publicado: (2013)

Tip60 Phosphorylation at Ser 99 Is Essential for Autophagy Induction in Bombyx mori
por: Wu, Wenmei, et al.
Publicado: (2020)

Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity
por: Chang, Mingxin, et al.
Publicado: (2020)

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth
por: Bhattacharjee, Sayani, et al.
Publicado: (2022)

VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases
por: Ekstrom, Thomas L., et al.
Publicado: (2021)

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma
por: Zhang, Mengyi, et al.
Publicado: (2019)

PARP1-Erk synergism in proliferating cells
por: Visochek, Leonid, et al.
Publicado: (2018)

GSK3β Inhibition by Phosphorylation at Ser(389) Controls Neuroinflammation
por: Calvo, Belen, et al.
Publicado: (2022)

DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors
por: Folly-Kossi, Helena, et al.
Publicado: (2023)

BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
por: Kong, Yangyang, et al.
Publicado: (2022)

The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression
por: Kim, Tae Hoon, et al.
Publicado: (2010)

Development of 1-(4-(Substituted)piperazin-1-yl)-2-((2-((4-methoxybenzyl)thio)pyrimidin-4-yl)oxy)ethanones That Target Poly (ADP-Ribose) Polymerase in Human Breast Cancer Cells
por: Deveshegowda, Suresha N., et al.
Publicado: (2022)

Nano-Zirconium Dioxide Catalyzed Multicomponent Synthesis of Bioactive Pyranopyrazoles That Target Cyclin Dependent Kinase 1 in Human Breast Cancer Cells
por: Basappa, Basappa, et al.
Publicado: (2023)

Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair
por: Croglio, Michael P., et al.
Publicado: (2016)

Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition
por: Al-Sudani, Hussein, et al.
Publicado: (2023)

Splicing inhibition decreases phosphorylation level of Ser2 in Pol II CTD
por: Koga, Mitsunori, et al.
Publicado: (2015)

Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation
por: Bueno-Carrasco, María Teresa, et al.
Publicado: (2022)

Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer
por: Zhang, Ning, et al.
Publicado: (2021)

Machine Learning for Endometrial Cancer Prediction and Prognostication
por: Bhardwaj, Vipul, et al.
Publicado: (2022)

Inhibition of Transcription Induces Phosphorylation of YB-1 at Ser102 and Its Accumulation in the Nucleus
por: Kretov, Dmitry A., et al.
Publicado: (2019)

Selective inhibition of phosphodiesterase 4D increases tau phosphorylation at Ser214 residue
por: Villa, Viviana, et al.
Publicado: (2022)

Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213
por: Kuo, Ying-Yu, et al.
Publicado: (2019)

Mitochondrial Protection by PARP Inhibition
por: Gallyas Jr., Ferenc, et al.
Publicado: (2020)

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
por: Banerjee, Arindam, et al.
Publicado: (2011)

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
por: Chong, Qing-Yun, et al.
Publicado: (2017)

Levonorgestrel Inhibits Human Endometrial Cell Proliferation through the Upregulation of Gap Junctional Intercellular Communication via the Nuclear Translocation of Ser255 Phosphorylated Cx43
por: Zhao, Xiaomiao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eb3mge9n0kn2orr23ddhq3tvg1